Skip to main content

Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement

Journal of Endocrinological Investigation volume 13, pages 849–853 (1990)Cite this article

Abstract

Hypogonadism is a common finding in idiopathic hemochromatosis. Most studies have localized the defect to either the pituitary gland or the testes. We describe a case with evidence that favors the likely concomitant involvement of the hypothalamus as a factor in the observed hypogonadism. A clinically hypogonadal male with hemochromatosis had a low testosterone concentration with inappropriately normal serum LH levels. Leydig cell function was intact, as demonstrated by a normal increase in serum testosterone following HCG administration. However, although the pituitary secretion of LH was normal in response to GnRH stimulation, clomiphene administration did not produce an increase in LH and FSH, suggesting that there was a defect in the hypothalamic GnRH response. Since the FSH and prolactin responses to stimulatory testing were inadequate, coexisting pituitary dysfunction was likely also present. We conclude that this man had hypogonadism with laboratory evidence for a combined defect in hypothalamic and pituitary function.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Stocks A.E., Martin F.I.R. Pituitary function in hemochromatosis. Am. J. Med. 45: 839, 1982.

    Article  Google Scholar 

  2. Simon M., Franchimont P., Murie N., Ferrand B., van Cauwenberge H., Hourel M. Study of somatotropic and gonadotropic pituitary function in idiopathic hemochromatosis (31 cases). Eur. J. Clin. Invest. 2: 384, 1972.

    CAS  PubMed  Article  Google Scholar 

  3. Tournaire J., Fevre M., Mazenod B., Ponsin G. Effects of clomiphene citrate and synthetic LHRH on serum luteinizing hormone (LH) in men with idiopathic hemochromatosis. J. Clin. Endocrinol. Metab. 38: 1122, 1974.

    CAS  PubMed  Article  Google Scholar 

  4. Walsh C.H., Wright A.D., Williams J.W., Holder G. A study of pituitary function in patients with idiopathic hemochromatosis. J. Clin. Endocrinol. Metab. 43: 866, 1976.

    CAS  PubMed  Article  Google Scholar 

  5. Bezwoda W.R., Bothwell T.H., Van der Walt LA., Kronheim S., Pimstone B.L. An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis. Clin. Endocrinol. (Oxf.) 6: 377, 1977.

    CAS  Article  Google Scholar 

  6. Edwards C.Q., Cartwright G.E., Skolnick M.H, Amos D.B. Homozygosity for hemochromatosis: clinical manifestations. Ann. Intern. Med. 93: 519, 1980.

    CAS  PubMed  Article  Google Scholar 

  7. Milder M.S., Cook J.D., Stray S., Finch C.A. Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 59: 34, 1980.

    CAS  Article  Google Scholar 

  8. Edwards C.Q., Dadone M.M., Skolnick M.H, Kushner J.P. Hereditary hemochromatosis. Clin. Haematology 11: 411, 1982.

    CAS  Google Scholar 

  9. Crosby W.H. Hemochromatosis: current concepts and management. Hosp. Pract. 75: 173, 1987.

    Google Scholar 

  10. Borwein S., Ghent C.N., Valberg L.S. Diagnostic efficacy of screening tests for hereditary hemochromatosis. Can. Med. Assoc. J. 131: 895, 1984.

    CAS  PubMed Central  PubMed  Google Scholar 

  11. Kelly T.M., Edwards C.Q., Meikle A.W., Kushner J.P. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann. Intern. Med. 101: 629, 1984.

    CAS  PubMed  Article  Google Scholar 

  12. Peillon F., Racadot J. Modifications histopathologiques de I’hypophyse dans six cas d’hemochromatose. Ann. Endocrinol. (Paris) 30: 800, 1969.

    CAS  Google Scholar 

  13. Williams T.C., Frohman L.A. Hypothalamic dysfunction associated with hemochromatosis. Ann. Intern. Med. 103: 550, 1985.

    CAS  PubMed  Article  Google Scholar 

  14. Iyer R., Duckworth W.C., Solomon S.S. Hypogonadism in idiopathic hemochromatosis. Arch. Intern. Med. 141: 517, 1981.

    CAS  PubMed  Article  Google Scholar 

  15. Snyder P.J., Rudenstein R.S., Gardner D.F., Rothman G. Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism. J. Clin. Endocrinol. Metab. 48: 864, 1979.

    CAS  PubMed  Article  Google Scholar 

  16. Lufkin E.G., Baldus W.P., Bergstralh E.J., Kao P.C. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin. Proc. 62: 473, 1987.

    CAS  PubMed  Article  Google Scholar 

  17. McNeil L.W., McKee L.C., Lorder D., Rabin D. The endocrine manifestations of hemochromatosis. Am. J. Med. Sci. 285: 7, 1983.

    CAS  PubMed  Article  Google Scholar 

  18. Siemons L.J., Mahler C.H. Hypogonadotropic hypogonadism in hemochroma tosis: recovery of reproductive function after iron depletion. J. Clin. Endocrinol. Metab. 65: 585, 1987.

    CAS  PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Medicine, Division of Endocrinology, Room 781, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada

    K. Siminoski &  P. G. Walfish

  2. Department of Clinical Biochemistry, Mount Sinai Hospital and Medical School, University of Toronto, Toronto, Canada

    M. D’Costa

Authors
  1. K. Siminoski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D’Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. G. Walfish
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Siminoski, K., D’Costa, M. & Walfish, P.G. Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement. J Endocrinol Invest 13, 849–853 (1990). https://doi.org/10.1007/BF03349640

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349640

Key-words

  • Hemochromatosis
  • hypogonadism
  • hypothalamic and pituitary
  • clomiphene and GnRH testing